Docs
🇬🇧
en
Mint Work
Sign in
Get Started
By
v1
Phase II Study of FavId (Tumor-Specific Idiotype-KLH) and Soluble GM-CSF Immunotherapy in Patients With Stable or Progressive Grade 1 and 2 Follicular B-Cell Lymphomas
Unknown
U
Unknown
NobleID
NI4P82W31R86S03
Type:
Journal Article
Claim Your Authorship
Cite
Sign in to see the full record
Creating an account is free.
Sign in
Create an account
For data access, contact
info@nobleid.org
.